Global T-Cell Immunotherapy Market Research Report 2021
- Published Date: 2021-04-15
- Report ID: 93670
- Pages: 82
-
Format:
Prudent Markets Predicts that T-Cell Immunotherapy Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global T-Cell Immunotherapy Market Overview:
Global T-Cell Immunotherapy Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of T-Cell Immunotherapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on T-Cell Immunotherapy Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the T-Cell Immunotherapy market in 2020.
Global T-Cell Immunotherapy Market Segmentation
By Type, T-Cell Immunotherapy market has been segmented into:
CAR-T
TCR
TIL Therapies
By Application, T-Cell Immunotherapy market has been segmented into:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in T-Cell Immunotherapy market are:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
1. Market Overview of T-Cell Immunotherapy
1.1 T-Cell Immunotherapy Market Overview
1.1.1 T-Cell Immunotherapy Product Scope
1.1.2 Market Status and Outlook
1.2 T-Cell Immunotherapy Market Size by Regions: 2015 VS 2021 VS 2026
1.3 T-Cell Immunotherapy Historic Market Size by Regions (2015-2020)
1.4 T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact T-Cell Immunotherapy Sales Market by Type (2015-2026)
2.1 Global T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
2.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)
2.3 CAR-T
2.4 TCR
2.5 TIL Therapies
3. Covid-19 Impact T-Cell Immunotherapy Sales Market by Application (2015-2026)
3.1 Global T-Cell Immunotherapy Historic Market Size by Application (2015-2020)
3.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)
3.3 Stomach Cancer
3.4 Lung Cancer
3.5 Colorectal Cancer
3.6 Esophagus Cancer
3.7 Pancreatic Cancer
3.8 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global T-Cell Immunotherapy Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global T-Cell Immunotherapy Revenue Market Share by Manufacturers (2015-2020)
4.3 Global T-Cell Immunotherapy Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in T-Cell Immunotherapy Business
5.1 Adaptimmune
5.1.1 Adaptimmune Company Profile
5.1.2 Adaptimmune T-Cell Immunotherapy Product Specification
5.1.3 Adaptimmune T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Altor Bioscience Corporation
5.2.1 Altor Bioscience Corporation Company Profile
5.2.2 Altor Bioscience Corporation T-Cell Immunotherapy Product Specification
5.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Cellectis
5.3.1 Cellectis Company Profile
5.3.2 Cellectis T-Cell Immunotherapy Product Specification
5.3.3 Cellectis T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Juno Therapeutics
5.4.1 Juno Therapeutics Company Profile
5.4.2 Juno Therapeutics T-Cell Immunotherapy Product Specification
5.4.3 Juno Therapeutics T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Kite Pharma
5.5.1 Kite Pharma Company Profile
5.5.2 Kite Pharma T-Cell Immunotherapy Product Specification
5.5.3 Kite Pharma T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novartis
5.6.1 Novartis Company Profile
5.6.2 Novartis T-Cell Immunotherapy Product Specification
5.6.3 Novartis T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Takara Bio
5.7.1 Takara Bio Company Profile
5.7.2 Takara Bio T-Cell Immunotherapy Product Specification
5.7.3 Takara Bio T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Unum Therapeutics
5.8.1 Unum Therapeutics Company Profile
5.8.2 Unum Therapeutics T-Cell Immunotherapy Product Specification
5.8.3 Unum Therapeutics T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America T-Cell Immunotherapy Market Size (2015-2026)
6.2 North America T-Cell Immunotherapy Key Players in North America (2015-2020)
6.3 North America T-Cell Immunotherapy Market Size by Type (2015-2020)
6.4 North America T-Cell Immunotherapy Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia T-Cell Immunotherapy Market Size (2015-2026)
7.2 East Asia T-Cell Immunotherapy Key Players in North America (2015-2020)
7.3 East Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
7.4 East Asia T-Cell Immunotherapy Market Size by Application (2015-2020)
8. Europe
8.1 Europe T-Cell Immunotherapy Market Size (2015-2026)
8.2 Europe T-Cell Immunotherapy Key Players in North America (2015-2020)
8.3 Europe T-Cell Immunotherapy Market Size by Type (2015-2020)
8.4 Europe T-Cell Immunotherapy Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia T-Cell Immunotherapy Market Size (2015-2026)
9.2 South Asia T-Cell Immunotherapy Key Players in North America (2015-2020)
9.3 South Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
9.4 South Asia T-Cell Immunotherapy Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia T-Cell Immunotherapy Market Size (2015-2026)
10.2 Southeast Asia T-Cell Immunotherapy Key Players in North America (2015-2020)
10.3 Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East T-Cell Immunotherapy Market Size (2015-2026)
11.2 Middle East T-Cell Immunotherapy Key Players in North America (2015-2020)
11.3 Middle East T-Cell Immunotherapy Market Size by Type (2015-2020)
11.4 Middle East T-Cell Immunotherapy Market Size by Application (2015-2020)
12. Africa
12.1 Africa T-Cell Immunotherapy Market Size (2015-2026)
12.2 Africa T-Cell Immunotherapy Key Players in North America (2015-2020)
12.3 Africa T-Cell Immunotherapy Market Size by Type (2015-2020)
12.4 Africa T-Cell Immunotherapy Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania T-Cell Immunotherapy Market Size (2015-2026)
13.2 Oceania T-Cell Immunotherapy Key Players in North America (2015-2020)
13.3 Oceania T-Cell Immunotherapy Market Size by Type (2015-2020)
13.4 Oceania T-Cell Immunotherapy Market Size by Application (2015-2020)
14. South America
14.1 South America T-Cell Immunotherapy Market Size (2015-2026)
14.2 South America T-Cell Immunotherapy Key Players in North America (2015-2020)
14.3 South America T-Cell Immunotherapy Market Size by Type (2015-2020)
14.4 South America T-Cell Immunotherapy Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World T-Cell Immunotherapy Market Size (2015-2026)
15.2 Rest of the World T-Cell Immunotherapy Key Players in North America (2015-2020)
15.3 Rest of the World T-Cell Immunotherapy Market Size by Type (2015-2020)
15.4 Rest of the World T-Cell Immunotherapy Market Size by Application (2015-2020)
16 T-Cell Immunotherapy Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
